Want to correct or add a campaign to our database?
Submit request

App “Strama Nationell”

Title or slogan
App “Strama Nationell”
Leading Institution
STRAMA (Swedish Strategic Programme Against Antibiotic Resistance)
Source

-Available at https://strama.se/ and findable at https://janusinfo.se/behandling/stramastockholm/informationsmaterial.4.10adba9e1616f8edbc9bcad.html
- Considered as a best practice by International Coalition of Medicines Regulatory Authorities (ICM

More+ -Available at https://strama.se/ and findable at https://janusinfo.se/behandling/stramastockholm/informationsmaterial.4.10adba9e1616f8edbc9bcad.html
- Considered as a best practice by International Coalition of Medicines Regulatory Authorities (ICMRA) (Check page 29 of the report https://www.icmra.info/drupal/sites/default/files/2022-11/amr_best_practices_report.pdf)
- Mobile application: https://strama.se/behandlingsrekommendationer/app-strama-nationell/
- Link to App: https://strama-nationell.infosynk.se/
- Article about App at eMagazine Page 38-39: https://etidning.infektion.net/p/infektionslakaren/infektionslakaren-2-2025/r/21/40-41/2071/1905623
Country/Countries
Sweden
Original language
Swedish
Available Language(s)
Swedish
Contact e-mail
info@softwerk.se
Campaign link
https://strama.se/behandlingsrekommendationer/app-strama-nationell/
Objective(s)
1. Reduce unnecessary or inappropriate antibiotic prescribing in outpatient and inpatient care.
2. Promote correct antibiotic use in line with evidence and current resistance trends.
3. Make trusted recommendations easily accessible to practitioners nationwide.
4. Provide quick, easy, and reliable access to national antibiotic treatment recommendations.
Target audience
Nurses
General practitioners
Medical doctors
Medical students
Campaign Scope
National
Communication Channels Used
Mobile Application
websites/blogs
Campaign Material(s)
Mobile app
Guideline documentation
Key messages
Potentially:
1. “Rätt antibiotika, i rätt tid, till rätt patient” → “The right antibiotic, at the right time, for the right patient.”
2. Use narrow-spectrum antibiotics when possible.
3. Adjust treatment based on local resistance trends and patient-specific factors.
Campaign Focus
Human health
Campaign Setting
GP practice
Walk in clinics
Hospital
Telehealth
emergency rooms
Use of Scientific Evidence
Yes
Visual and Symbolic Elements
Use of colors
Icongraphy
Symbols
Speech bubbles
Favorites/Bookmarks
Quick tips
Educational model applied
Transmissive
Content Complexity Level
Specialized
Content accessibility
No
Diversity and Inclusion
No
Involvement of Vulnerable Groups
No
Cultural Sensitivity and Contextualization
Yes
Replicability
Yes
Content usage license
Free
Campaign Status
Active
Evaluation methods used
Prescription surveillance
Resistance pattern monitoring
Provider feedback
Policy benchmarking
Download analytics
In-app usage statistics
User feedback surveys
Community participation in evaluation
Yes
Quantitative impact indicators
Download
Adherence rates
Shorter treatment duration
Reduction in total antibiotic prescribing
App usage rates
Session lenghts
Qualitative impact indicators
Attitude changes
Patient satisfaction
Practitioner acceptance of guidelines
Level of awareness
User satisfaction
Measured results
Known from https://www.icmra.info/drupal/sites/default/files/2022-11/amr_best_practices_report.pdf:
1. Achieved Sweden’s “250-prescriptions-per-1000” goal ahead of schedule.
2. Significant behavior changes: 2.1. Decline in quinolone use for UTIs. 2.2. Elimination of antibiotics for uncomplicated otitis media in children.
Accessible formats for hearing impaired users not provided
Accessible formats for visually impaired users not provided
No adaptation for different age groups
Frequently Asked Questions (FAQs) section not included
Campaign timeline information incomplete or missing
Interactive features not included
Reporting on results or impact not found
Outreach activities not documented
1. No personalized guidance based on local resistance data or EHR integration.
2. Underutilization in non-clinical environments (e.g., patient-facing versions).
3. No built-in educational tutorials or onboarding for new users.
Multilingual materials may reach more diverse communities.
Tailoring content to specific groups (e.g., parents, seniors, teens) may enhance impact.
Partnering with schools, municipalities, and local groups may enhance credibility and distribution.
Based on International Coalition of Medicines Regulatory Authorities (ICMRA) (Check page 29 of the report https://www.icmra.info/drupal/sites/default/files/2022-11/amr_best_practices_report.pdf)
1. Centralized and trusted guidance can shift national prescribing behavior over time.
2. Combining print (pamphlets) and tech (app) ensures accessibility across generations.
3. Ongoing co-creation with specialists and feedback loops are key to long-term relevance.
4. Real-time, mobile-enabled clinical decision support is a powerful tool in stewardship.
Digital Access Bias
Digital Literacy Bias
Disability Accessibility Bias
Educational Bias
Evaluation Absence Bias
Involvement Bias
Vulnerable Groups Bias
1. Regional digital access disparity may affect adoption.
2. Language barriers: content only in Swedish.
3. Assumes high clinical literacy—may be difficult for interns/new practitioners without context.



Limited accessibility
Limited reach / Single channel
1. No gamification or behavioral nudges.
2. Lacks patient-facing version or visual translation tools.
3. No real-time resistance tracking by region.
Dedicated website or online portal
Easy to locate materials
1. High trust and adoption by Swedish prescribers.
2. Evidence-based, regularly updated guidance.
3. Cross-sector collaboration (PHAS, SMPA, STRAMA, specialty societies).
4. Simple, fast access at point of care.
5. Modular and expandable across new specialties (e.g., pediatrics added in 2025).